136 related articles for article (PubMed ID: 37343171)
1. Patterns of practice regarding use of radiation therapy following radical prostatectomy: A survey of Radiation Oncologists and Urologists in Australia and New Zealand.
Lawless A; Kneebone A; Armstrong S; Chander S; Christie D; Finnigan R; Hayden A; Higgs B; Knox M; Sasso G; Sidhom M; Shakespeare TP; Holt T
J Med Imaging Radiat Oncol; 2023 Aug; 67(5):556-563. PubMed ID: 37343171
[TBL] [Abstract][Full Text] [Related]
2. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.
Kishan AU; Duchesne G; Wang PC; Rwigema JM; Kishan AU; Saigal C; Rettig M; Steinberg ML; King CR
Am J Clin Oncol; 2018 Aug; 41(8):739-746. PubMed ID: 28301348
[TBL] [Abstract][Full Text] [Related]
3. Post-prostatectomy adjuvant androgen deprivation therapy- Current opinions and practices of Canadian urologists.
Levitt M; Nayak AL; Fergusson DA; Lavallee LT; Morash C; Cagiannos I; Flaman AS; Breau RH
Urol Oncol; 2022 Feb; 40(2):57.e9-57.e14. PubMed ID: 34303596
[TBL] [Abstract][Full Text] [Related]
4. Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists.
Brown B; Egger S; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
J Med Imaging Radiat Oncol; 2016 Dec; 60(6):744-755. PubMed ID: 27346844
[TBL] [Abstract][Full Text] [Related]
5. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.
Lavallée LT; Fergusson D; Mallick R; Grenon R; Morgan SC; Momoli F; Witiuk K; Morash C; Cagiannos I; Breau RH
PLoS One; 2013; 8(11):e79773. PubMed ID: 24224003
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.
Bristow B; Aldehaim M; Bonin K; Lam CCK; Wan SJ; Cao X; Szumacher E
J Cancer Educ; 2018 Dec; 33(6):1195-1200. PubMed ID: 28573519
[TBL] [Abstract][Full Text] [Related]
8. Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by
Devos G; Witters M; Moris L; Van den Broeck T; Berghen C; Devlies W; De Meerleer G; Goffin K; Jentjens S; Albersen M; Van Poppel H; Everaerts W; Joniau S
World J Urol; 2021 Feb; 39(2):399-406. PubMed ID: 32417995
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Kneebone A; Fraser-Browne C; Duchesne GM; Fisher R; Frydenberg M; Herschtal A; Williams SG; Brown C; Delprado W; Haworth A; Joseph DJ; Martin JM; Matthews JHL; Millar JL; Sidhom M; Spry N; Tang CI; Turner S; Wiltshire KL; Woo HH; Davis ID; Lim TS; Pearse M
Lancet Oncol; 2020 Oct; 21(10):1331-1340. PubMed ID: 33002437
[TBL] [Abstract][Full Text] [Related]
10. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Rogowski P; Trapp C; von Bestenbostel R; Eze C; Ganswindt U; Li M; Unterrainer M; Zacherl MJ; Ilhan H; Beyer L; Kretschmer A; Bartenstein P; Stief C; Belka C; Schmidt-Hegemann NS
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1417-1428. PubMed ID: 34628521
[TBL] [Abstract][Full Text] [Related]
11. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.
Sidhom MA; Kneebone AB; Lehman M; Wiltshire KL; Millar JL; Mukherjee RK; Shakespeare TP; Tai KH
Radiother Oncol; 2008 Jul; 88(1):10-9. PubMed ID: 18514340
[TBL] [Abstract][Full Text] [Related]
12. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.
Sylvester J; Grimm P; Blasco J; Meier R; Spiegel J; Heaney C; Cavanagh W
Urology; 2001 Aug; 58(2 Suppl 1):65-70. PubMed ID: 11502452
[TBL] [Abstract][Full Text] [Related]
13. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.
Lieng H; Hayden AJ; Christie DRH; Davis BJ; Eade TN; Emmett L; Holt T; Hruby G; Pryor D; Shakespeare TP; Sidhom M; Skala M; Wiltshire K; Yaxley J; Kneebone A
Radiother Oncol; 2018 Nov; 129(2):377-386. PubMed ID: 30037499
[TBL] [Abstract][Full Text] [Related]
15. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
Jang JW; Hwang WT; Guzzo TJ; Wein AJ; Haas NB; Both S; Vapiwala N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1493-9. PubMed ID: 22401922
[TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
[TBL] [Abstract][Full Text] [Related]
17. Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.
De Bari B; Mazzola R; Aiello D; Fersino S; Gregucci F; Alongi P; Nicodemo M; Cavalleri S; Salgarello M; Alongi F
Radiol Med; 2018 Sep; 123(9):719-725. PubMed ID: 29687208
[TBL] [Abstract][Full Text] [Related]
18. Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis.
Egger S; Smith DP; Brown BB; Kneebone AB; Dominello A; Brooks AJ; Young J; Xhilaga M; Haines M; O'Connell DL
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):134-143. PubMed ID: 31793211
[TBL] [Abstract][Full Text] [Related]
19. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.
Dal Pra A; Panje C; Zilli T; Arnold W; Brouwer K; Garcia H; Glatzer M; Gomez S; Herrera F; Kaouthar K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen DR; Engeler D; Putora PM
Strahlenther Onkol; 2018 Jan; 194(1):9-16. PubMed ID: 28656373
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy.
Zamboglou C; Strouthos I; Sahlmann J; Farolfi A; Serani F; Medici F; Cavallini L; Morganti AG; Trapp C; Koerber SA; Peeken JC; Vogel MME; Schiller K; Combs SE; Eiber M; Vrachimis A; Ferentinos K; Spohn SKB; Kirste S; Gratzke C; Ruf J; Grosu AL; Ceci F; Fendler WP; Miksch J; Kroeze S; Guckenberger M; Lanzafame H; Fanti S; Hruby G; Wiegel T; Emmett L; Schmidt-Hegemann NS; Henkenberens C
Int J Radiat Oncol Biol Phys; 2022 Aug; 113(5):1015-1024. PubMed ID: 35659629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
